Biotransformation of dehydroepiandrosterone with Macrophomina phaseolina and β-glucuronidase inhibitory activity of transformed products

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 27, Issue 3, 2012, Pages 348-355

  Choudhary, M Iqbal ^a,b   Zafar, Salman ^a   Khan, Naik Tameen ^a   Ahmad, Saeed ^c   Noreen, Shagufta ^a   Marasini, Bishnu P ^a   Al Khedhairy, Abdulaziz A ^b   Atta Ur Rahman, ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

Author keywords

chymotrypsin inhibition; glucuronidase inhibition; Dehydroepiandrosterone; Macrophomina phaseolina; Microbial transformation

Indexed keywords

ANDROST 4 ENE 17 BETA OL 3 ONE; ANDROST 4 ENE 3BETA OL 6,17 DIONE; ANDROST 4 ENE 3BETA,7BETA,17BETA TRIOL; ANDROST 4,6 DIENE 17BETA OL 3 ONE; ANDROST 5 ENE 3BETA,7ALPHA,17BETA TRIOL; ANDROSTANEDIONE; ANDROSTENEDIOL; ANDROSTENEDIONE; BETA GLUCURONIDASE; CHYMOTRYPSIN A; DRUG METABOLITE; PRASTERONE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG TRANSFORMATION; ENZYME ACTIVITY; ENZYME INHIBITION; FERMENTATION; FUNGUS; IC 50; MACROPHOMINA PHASEOLINA; NONHUMAN; PRIORITY JOURNAL;

ASCOMYCOTA; BIOTRANSFORMATION; DEHYDROEPIANDROSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLUCURONIDASE; MOLECULAR CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

MACROPHOMINA PHASEOLINA;

EID: 84860384777     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2011.590804     Document Type: Article

References (51)

1. Lacroix I, Biton J, Azerad R. Microbial models of drug metabolism: microbial transformations of Trimegestone (RU27987), a 3-keto-delta(4,9(10))-19- norsteroid drug. Bioorg Med Chem 1999;7:2329-2341. (Pubitemid 30122735)
2. Zaks A, Dodds DR. Application of biocatalysis and biotransformations to the synthesis of pharmaceuticals. Drug Discov Today 1997;2:513-531. (Pubitemid 27512942)
3. Dubey KK, Ray AR, Behera BK. Production of demethylated colchicine through microbial transformation and scale-up process development. Process Biochem 2008;43:251-257.
4. Fotherby K. The isolation of 3 beta-hydroxy-delta 5-steroids from the urine of normal men. Biochem J 1958;69:596-600.
5. Daynes RA, Dudley DJ, Araneo BA. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol 1990;20:793-802. (Pubitemid 20167034)
6. Danenberg HD, Alpert G, Lustig S, Ben-Nathan D. Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production. Antimicrob Agents Chemother 1992;36:2275-2279.
7. Danenberg HD, Ben-Yehuda A, Zakay-Rones Z, Friedman G. Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine 1995;13:1445-1448.
8. Solerte SB, Fioravanti M, Vignati G, Giustina A, Cravello L, Ferrari E. Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. J Clin Endocrinol Metab 1999;84: 3260-3267. (Pubitemid 30646954)
9. Compagnone NA, Mellon SH. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol 2000;21:1-56. (Pubitemid 30105920)
10. Choudhary MI, Shah SA, Musharraf SG, Shaheen F, Atta-Ur- Rahman. Microbial transformation of dehydroepiandrosterone. Nat Prod Res 2003;17:215-220. (Pubitemid 36581830)
11. Madyastha KM, Joseph T. Transformation of dehydroepiandrosterone and pregnenolone by Mucor piriformis. Appl Microbiol Biotechnol 1995;44:339-343. (Pubitemid 26024351)
12. Fernandes P, Cruz A, Angelova B, Pinheiro HM, Cabral, JMS. Microbial conversion of steroid compounds: recent developments. Enzyme Microb Technol 2003;32:688-705. (Pubitemid 36513765)
13. Romano A, Romano D, Ragg E, Costantino F, Lenna R, Gandolfi R et al. Steroid hydroxylations with Botryodiplodia malorum and Colletotrichum lini. Steroids 2006;71:429-434.
14. Kolek T. Biotransformation XLVII: transformations of 5-ene steroids in Fusarium culmorum culture. J Steroid Biochem Mol Biol 1999;71:83-90.
15. Hong-Min L, Heping L, Lihong S, Jian W. Synthesis of steroidal lactone by Penicillium citeo-viride. Steroids 2006;71:931-934.
16. Lamm AS, Chen AR, Reynolds WF, Reese PB. Steroid hydroxylation by Whetzelinia sclerotiorum, Phanerochaete chrysosporium and Mucor plumbeus. Steroids 2007;72:713-722. (Pubitemid 47126566)
17. Hunter AC, Mills PW, Dedi C, Dodd HT. Predominant allylic hydroxylation at carbons 6 and 7 of 4 and 5-ene functionalized steroids by the thermophilic fungus Rhizomucor tauricus IMI23312. J Steroid Biochem Mol Biol 2008;108:155-163. (Pubitemid 351173830)
18. Janeczko T, Dmochowska-Gladysz J, Kostrzewa-Suslow E, Bialonska A, Ciunik Z. Biotransformations of steroid compounds by Chaetomium sp. KCH 6651. Steroids 2009;74:657-661.
19. Hunter AC, Coyle E, Morse F, Dedi C, Dodd HT, Koussoroplis S. Transformation of 5-ene steroids by the fungus Aspergillus tamarii KITA: Mixed molecular fate in lactonization and hydroxylation pathways with identification of a putative 3β-hydroxy-steroid dehydrogenase/?5-?4 isomerase pathway. Biochim et Biophys Acta 2009;1719:110-117.
20. Lobastova TG, Donova MV. The microbial formation of lactones from dehydroepiandrosterone. Special abstracts/J Biotechnol 2010;1505:51-5576.
21. Huang LH, Li J, Xu G, Zhang XH, Wang YG, Yin YL et al. Biotransformation of dehydroepiandrosterone (DHEA) with Penicillium griseopurpureum Smith and Penicillium glabrum (Wehmer) Westling. Steroids 2010;75:1039-1046.
22. Liu Y, Cheng KD, Zhu P, Feng WH, Meng C, Zhu HX et al. [Biotransformation of dehydroepiandrosterone by hairy root cultures of Anisodus tanguticus]. Yao Xue Xue Bao 2004;39:445-448. (Pubitemid 39420696)
23. Weill-Engerer S, David JP, Sazdovitch V, Liere P, Schumacher M, Delacourte A et al. In vitro metabolism of dehydroepiandrosterone (DHEA) to 7alpha-hydroxy-DHEA and Delta5-androstene- 3beta,17beta-diol in specific regions of the aging brain from Alzheimer s and non-demented patients. Brain Res 2003;969:117-125. (Pubitemid 36369619)
24. Chalbot S, Morfin R. Human liver S9 fractions: metabolism of dehydroepiandrosterone, epiandrosterone, and related 7-hydroxylated derivatives. Drug Metab Dispos 2005;33:563-569. (Pubitemid 40393200)
25. Marwah A, Marwah P, Lardy H. Ergosteroids. VI. Metabolism of dehydroepiandrosterone by rat liver in vitro: a liquid chromatographic-mass spectrometric study. J Chromatogr B Analyt Technol Biomed Life Sci 2002;767:285-299. (Pubitemid 34142320)
26. Jellinck PH, Lee SJ, McEwen BS. Metabolism of dehydroepiandrosterone by rat hippocampal cells in culture: possible role of aromatization and 7-hydroxylation in neuroprotection. J Steroid Biochem Mol Biol 2001;78:313-317. (Pubitemid 33079106)
27. Jellinck PH, Croft G, McEwen BS, Blackmore AG, Jones G, Byford V, Bulloch K. Metabolism of dehydroepiandrosterone by rat hippocampal cells in culture: possible role of aromatization and 7-hydroxylation in neuroprotection. J Steroid Biochem Mol Biol 2005;93:81-86.
28. Lavallée B, Provost PR, Kahwash Z, Nestler JE, Bélanger A. Effect of insulin on serum levels of dehydroepiandrosterone metabolites in men. Clin Endocrinol (Oxf) 1997;46:93-100. (Pubitemid 27072852)
29. Kavak DD, Altiok E, Bayraktar O, Ulku S. Pistacia terebinthus extract: As a potential antioxidant, antimicrobial and possible β-glucuronidase inhibitor. J Mol Catal B: Enzym 2010;64:167-171.
30. Rauh R, Diakov A, Tzschoppe A, Korbmacher J, Azad AK, Cuppens H et al. A mutation of the epithelial sodium channel associated with atypical cystic fibrosis increases channel open probability and reduces Na+ self inhibition. J Physiol (Lond) 2010;588:1211-1225.
31. Stehlik C. Multiple interleukin-1beta-converting enzymes contribute to inflammatory arthritis. Arthritis Rheum 2009;60: 3524-3530.
32. Lam SK, Ng TB. A dimeric high-molecular-weight chymotrypsin inhibitor with antitumor and HIV-1 reverse transcriptase inhibitory activities from seeds of Acacia confusa. Phytomedicine 2010;17:621-625.
33. Choudhary MI, Musharraf SG, Ali RA, Atif M, Atta-ur-Rahman. Microbial transformation of antifertility agents, norethisterone and 17α- ethynylestradiol. Z Naturforsch 2004;59b:319-323. (Pubitemid 38526477)
34. Choudhary MI, Sultan S, Khan MT, Rahman AU. Microbial transformation of 17alpha-ethynyl- and 17alpha-ethylsteroids, and tyrosinase inhibitory activity of transformed products. Steroids 2005;70:798-802. (Pubitemid 41330981)
35. Choudhary MI, Khan NT, Musharraf SG, Anjum S, Atta-Ur- Rahman. Biotransformation of adrenosterone by filamentous fungus, Cunninghamella elegans. Steroids 2007;72:923-929. (Pubitemid 47600275)
36. Choudhary MI, Mohammad MY, Musharraf SG, Parvez M, Al-Aboudi A, Atta-ur-Rahman. New oxandrolone derivatives by biotransformation using Rhizopus stolonifer. Steroids 2009;74: 1040-1044.
37. Nunes RMD, Peixoto AF, Axet MR, Pereira MM, Moreno MJ, Kollár L, Claver C, Castillón S. J Mol Catal A: Chemical 2006;247:275-282.
38. Hu S, Genain G, Azerad R. Microbial transformation of steroids: contribution to 14 alpha-hydroxylations. Steroids 1995;60:337-352.
39. LI, H, Peng YU, Zhang H, Hong-Min LIU. Synthesis of 5-androstene- 3β,7α,17β-triol and 5-androstene-3β,7β,17β-triol. Chin J Chem 2008;26:1666-1668.
40. Labler L; Slama K; Sorm, F. Steroids. CXV. Toxic effects of some androstane derivatives on Pyrrhocoris apterus larvae. Collect Czech Chem Comm 1968;33:2226-2237.
41. Khan KM, Shujaat S, Rahat S, Hayat S, Atta-ur-Rahman, Choudhary MI. Beta-N-cyanoethyl acyl hydrazide derivatives: a new class of beta- glucuronidase inhibitors. Chem Pharm Bull 2002;50:1443-1446. (Pubitemid 41685609)
42. Jozef V, Gordon GG, Louis SA. Metabolism of 7α -3H-testosterone by human mandibular bone in vitro. Med Sci Res 1990;18:67-68. (Pubitemid 20034767)
43. Kaartinen E, Laukkanen M, Saure A. Metabolism of dehydroepiandrosterone by rat testicular homogenates; kinetic study at different temperatures; direct effect of 17 beta-oestradiol. Acta Endocrinol 1971;66:50-64.
44. Eunjeong K., Eunsook M. Chemoselective reduction of 1,4,6- cholestatrien-3-one and 1,4,6-androstatriene-3,17-dione by various hydride reagents. Steroids 2007;72:360-367.
45. Choudhary MI, Shah SA, Atta-ur-Rahman, Khan SN, Khan MT. Alpha-glucosidase and tyrosinase inhibitors from fungal hydroxylation of tibolone and hydroxytibolones. Steroids 2010;75:956-966.
46. Birkenmeier EH, Davisson MT, Beamer WG, Ganschow RE, Vogler CA, Gwynn B et al. Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. J Clin Invest 1989;83:1258-1266. (Pubitemid 19113040)
47. Sly WS, Quinton BA, McAlister WH, Rimoin DL. Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J Pediatr 1973;82:249-257.
48. Chang HW, Friedman ME, Hileman DL, Parish EJ. Inhibition of human synovial beta-glucuronidase by steroidal compounds. J Enzym Inhib 1992;6:331-335. (Pubitemid 23170841)
49. Kawasaki M, Hayashi T, Arisawa M, Morita N, Berganza LH. 8-Hydroxytricetin 7-glucuronide, a β-glucuronidase inhibitor from Scoparia dulcis. Phytochemistry 1988;27:3709-3711.
50. Hayashi T, Kawasaki M, Okamura K, Tamada Y, Morita N, Tezuka Y, Kikuchi T, Miwa Y, Taga T. Scoparic acid A, a betaglucuronidase inhibitor from Scoparia dulcis. J Nat Prod 1992;12:748-1755.
51. Kushinsky S, Chen VL. Urinary inhibitors of β-glucuronidase. Enzym Biol Clin 1967;8:266-282.